TELA Bio Inc.

NASDAQ: TELA · Real-Time Price · USD
1.63
0.03 (1.87%)
At close: Aug 15, 2025, 2:20 PM

TELA Bio Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-37.84M -46.66M -44.3M -33.28M
Depreciation & Amortization
1.01M 808K 1.19M 535K
Stock-Based Compensation
4.36M 5.03M 3.99M 3.66M
Other Working Capital
-1.62M 3.78M 4.04M 1.69M
Other Non-Cash Items
-4.12M 1.64M 4.13M 2.1M
Deferred Income Tax
-144K n/a n/a 14K
Change in Working Capital
-4.87M -1.67M -5.76M -3.47M
Operating Cash Flow
-41.59M -40.86M -40.75M -30.43M
Capital Expenditures
-989K -611K -1.87M -627K
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a -1M n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
4.45M 12K 1M n/a
Investing Cash Flow
4.45M -599K -1.87M -627K
Debt Repayment
n/a n/a 10M n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
138K -74K -3.55M n/a
Financial Cash Flow
43.06M 46.27M 40.85M 585K
Net Cash Flow
5.94M 4.97M -1.91M -30.46M
Free Cash Flow
-42.58M -41.47M -42.62M -31.06M